Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
2.620
+0.155 (6.29%)
At close: Jun 26, 2026, 4:00 PM EDT
2.610
-0.010 (-0.39%)
After-hours: Jun 26, 2026, 7:03 PM EDT
Anavex Life Sciences Employees
Anavex Life Sciences had 34 employees as of September 30, 2025. The number of employees decreased by 8 or -19.05% compared to the previous year.
Employees
34
Change (1Y)
-8
Growth (1Y)
-19.05%
Revenue / Employee
n/a
Profits / Employee
-$1,174,912
Market Cap
242.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Coherus Oncology | 145 |
| Foghorn Therapeutics | 106 |
| Orchestra BioMed Holdings | 86 |
| Armata Pharmaceuticals | 61 |
| Fulcrum Therapeutics | 55 |
| Protara Therapeutics | 46 |
| Whitehawk Therapeutics | 29 |
AVXL News
- 5 weeks ago - Anavex receives expected Nasdaq delinquency notification - TheFly
- 5 weeks ago - Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification - GlobeNewsWire
- 6 weeks ago - Anavex delays 10Q filing - TheFly
- 7 weeks ago - Anavex Life Sciences names Terrie Kellmeyer interim CEO, succeeding Missling - TheFly
- 7 weeks ago - Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer - GlobeNewsWire
- 7 weeks ago - Anavex initiated with a Buy at Rodman & Renshaw - TheFly
- 2 months ago - Anavex Life Sciences Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 2 months ago - Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer's Disease - GlobeNewsWire